Feb. 25, 2026
Novo Nordisk Inks $2.1B Deal for Oral Obesity Drugs
Partnership with Vivtex to develop next-generation oral biologics for obesity and diabetes
Feb. 23, 2026
Metastat and Allurion Technologies Compared in Critical Survey
Analysts believe Allurion Technologies has stronger consensus rating and higher potential upside than Metastat.
Feb. 22, 2026
Ironwood Pharmaceuticals to Host Q4 and Full Year 2025 Investor Call
The biotech company will provide an update on its gastrointestinal and rare disease therapies.
Feb. 15, 2026
Alnylam Pharmaceuticals Turns Profitable in Q4 2025
Biotech firm's strong financial results challenge bearish narratives
Feb. 14, 2026
Maze Therapeutics Highlights Upcoming MZE829 Kidney Data, Maps Phase 2 Plans for MZE782
CEO Jason Coloma discusses the company's genetics-driven approach to drug development at Guggenheim's Emerging Biotech Summit.
Feb. 14, 2026
American Well Focuses on Platform, Cost Cuts in Transformation
Digital health company narrows strategy, divests non-core activities to drive toward positive cash flow in Q4 2026
Feb. 13, 2026
American Well Focuses on Platform Amid Market Shift
Telehealth company narrows strategy, reduces costs, and eyes positive cash flow in 2026
Feb. 11, 2026
Polsinelli Expands Boston Presence with Healthcare Litigator Angelini
Veteran attorney Laura Angelini joins firm's healthcare litigation practice
Feb. 10, 2026
Boston Biotech Dash Bio Expands with New Lab in Waltham
The company's new 24,000-square-foot facility represents a fivefold increase in its footprint.
